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1. Introduction  
Cordyceps militaris (CM), also known as the caterpillar fungus, is a well-known, traditional 
Chinese medicine that can be artificially cultivated on a large scale (Fig. 1). In recent 
decades, CM extract has been reported to have different biological activities, such as anti-
tumor activity (Park et al., 2009) and immunomodulation (Shin et al., 2010). Similar to 
Cordyceps sinensis (CS), an expensive, wild-fruiting species of Cordyceps, CM can be used to 
treat certain respiratory diseases, such as asthma, bronchitis, and chronic obstructive 
pulmonary disease (COPD) (Paterson, 2008). In contrast to CS, CM can be artificially 
cultivated on a large scale and hence is much cheaper to produce. While CM has medicinal 
properties similar to CS, it is widely used as a substitute for CS in health supplements. A 
recent clinical trial demonstrated that naturally grown and cultivated mycelia of Cordyceps 
are effective for the treatment of asthma (Wang et al., 2007). In addition to the treatment of 
respiratory diseases, CM has beneficial therapeutic effects for patients with influenza A viral 
infections (Ohta et al., 2007).  
Recently, we demonstrated that the water extracts of both CS and CM can stimulate anion 
secretion across Calu-3 airway epithelia with similar prosecretory activities (Yue et al., 2008). 
Calu-3 monolayers have characteristics of both serous and mucus cells and more closely 
resemble submucosal glands (Shan et al., 2011). Therefore, our recent paper has challenged 
the traditional belief that natural Cordyceps has better therapeutic medicinal value than 
cultivated Cordyceps. We show that the two have similar pharmacological properties in 
stimulating transepithelial anion secretion in airway epithelia. While both CS and CM have 
established efficacies for the treatment of pulmonary disorders, the cellular mechanisms that 
are responsible for the medicinal properties of Cordyceps are not entirely clear. The aim of 
this chapter is to discuss the potential cellular mechanisms and signal transduction 
pathways underlying the prosecretory action of CS and CM extracts and their major 
ingredient, cordycepin. We propose that the activation of ion transport processes by 
Cordyceps extracts and cordycepin in airway epithelia may have clinical relevance and partly 
explain their traditional use in the treatment of respiratory diseases, such as asthma and 






to their anti-inflammatory effects on airway epithelial cells. Asthma is now defined as a 
chronic inflammatory disorder of the airways, in which many immune cells (e.g. mast cells, 
eosinophils) are involved. There are many similarities and differences between asthma and 
COPD, but a full description of their pathophysiology and management is beyond the scope 







Fig. 1. Photograph of Cordyceps militaris, showing the different parts of the fruiting bodies. 
2. Ion transport in airway epithelia 
2.1 Role of airway epithelia in transepithelial electrolyte and fluid transport 
Epithelial cells characteristically grow as distinct sheets that form the anatomical boundaries 
between the relatively stable internal environment of the body and the constantly changing 
environment of the outside world. Many epithelia have become specialized to permit the 
controlled secretion and/or absorption of salt and water. These transport processes can be 
controlled by hormones and neurotransmitters that bind to specific cell surface receptors. 
Receptor occupation causes the production of characteristic 'second messenger' signals 
within the cytoplasm, which then modifies cellular metabolism and evokes ion transport. 
This regulated transport of salt and water is essential to the integrated function of many 
organ systems, including the respiratory tract. 
The hydration of the normal airway surface is dependent on the active ion transport 
processes of the airway epithelia, which are highly water-permeable (Chambers et al., 2007). 
Airway fluid secretion is a passive process that is driven by osmotic forces generated by ion 
transport. The main determinant of a luminally directed osmotic gradient is the mucosal 
transport of chloride ions (Cl-) into the lumen. Airway Cl- secretion is an energy-dependent 
process that generates an electrical potential across the mucosal epithelium (i.e., 
electrogenic). Cations are drawn into the lumen by the established electrochemical gradient, 
and water loss is an obligatory consequence of the efflux of salt. The coordinated regulation 
and balance of Cl- secretion and Na+ reabsorption, therefore, controls the mass of salt (NaCl) 
on airway surfaces. This is important in maintaining the thickness and composition of 
airway surface liquid (ASL), which in turn affects airway mucus clearance (Tarran et al., 
2006). Mucus clearance is an important component of the innate defense of the lungs against 
disease. Abnormal ASL volume, salt content, or mucus clearance can compromise airway 
immunity and predispose the airway to various respiratory diseases and infection (Danahay 
and Jackson, 2005).  
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2.2 Stimulation of Cl
-
 secretion by cAMP and Ca
2+
  
The mechanism of airway Cl- secretion is well understood. Increases in cAMP levels activate 
Cl- secretion via luminal cystic fibrosis transmembrane conductance regulator (CFTR) Cl- 
channels (Boucher, 2002). In addition, cAMP also increases basolateral K+ conductance, 
probably via KvLQT1-type K+ channels, which hyperpolarize the membrane and increase the 
driving force for apical Cl- exit (Bardou et al., 2009). Calcium-activated Cl- channels (CaCCs) 
are also involved in Cl- secretion, and their molecular identity has recently been determined 
(Caputo et al., 2008). Increases in intracellular Ca2+ concentrations ([Ca2+]i) lead to the 
opening of CaCCs and basolateral SK4-type K+ channels (Bardou et al., 2009), which provide 
an additional driving force for Cl- exit through apical Cl- channels (i.e., CFTR and CaCCs). 
Therefore, [Ca2+]i and cAMP are the two major signal transduction cascades involved in the 
regulation of airway ion transport. 
3. Stimulation of ion transport by CM extract and its active ingredient, 
cordycepin, in Calu-3 and 16HBE14o- cells 
3.1 Calu-3 cells 
To study the effects of extracts of CS and CM, and its active ingredient, cordycepin, on ion 
transport activities in Calu-3 epithelia, the cells were grown on permeable supports 
(Transwell-COL membranes) until confluent (Wong et al., 2009a). Calu-3 cells have many 
properties of serous cells of the submucosal glands and express the highest levels of natural 
CFTR of any known immortalized cell line (Haws et al., 1994; Shen et al., 1994). The 
monolayers were mounted in Ussing chambers and bathed in normal Krebs-Henseleit 
solution with a basolateral-to-apical Cl- gradient. An increase in short-circuit currents (ISC), 
which is an index of electrogenic ion transport, was measured by an electrophysiological 
technique. Our data demonstrate that extracts of CS and CM, as well as its isolated 
compound, cordycepin, all stimulate ion transport in a dose-dependent manner in Calu-3 
monolayers. Apical application of 300 μg/ml CM extract or 300 μM cordycepin stimulates 
the highest peak increase in ISC. The transport mechanisms involve both basolateral Na+-K+-
2Cl- cotransporters and apical CFTR Cl- channels for the uptake and exit of Cl-, respectively 
(Yue et al., 2008). These data indicate for the first time that extracts of CS and CM, and 
cordycepin could stimulate transepithelial Cl- secretion and may therefore promote fluid 
secretion by human airway epithelial cells. Insufficient fluid secretion leads to airway 
dehydration, which hampers clearance of secreted mucus and promotes airway 
inflammatory conditions, such as asthma and bronchitis. In addition, the fluid lining the 
airway serves as an anatomical barrier between inspired pathogens/particulates and the 
epithelial surface. Decreased ion transport activity of the surface epithelium may therefore 
compromise its innate lung defense function and exacerbate airway inflammation (Clunes et 
al., 2008). Since Cordyceps has proven clinically efficacy for treating patients with chronic 
bronchitis and COPD, the effects observed in promoting Cl- secretion may partially explain 
the mechanism that underlies this efficacy. 
3.2 16HBE14o- cells 
Apart from the recent data on Calu-3 cells, our laboratory has further investigated the 






and cordycepin in 16HBE14o- cells, an immortalized cell line that was derived from human 
bronchial surface epithelium (Cozens et al., 1994). It is a good model to study transepithelial 
Cl- secretion (Bernard et al., 2003; Bernard et al., 2005), airway inflammation, and airway 
remodeling (Holgate et al., 1999; Kidney and Proud, 2000; Puddicombe et al., 2000). An 
electrophysiological technique, similar to that described above, was employed to examine 
the prosecretory effects of CM extract and cordycepin on 16HBE14o- cells. The involvement 
of various ion channels located at the apical and basolateral membranes was investigated by 
pharmacological approaches. Different ion channels inhibitors, such as CFTRinh-172 (CFTR 
inhibitor), DIDS (Ca2+ activated Cl- channel inhibitor), 293B (cAMP-dependent K+ channel 
blocker), etc., were used to delineate the transport mechanism. The involvement of different 
second messengers, such as Ca2+ or cAMP, was examined by fluorescence imaging 
techniques using specific pathway inhibitors. Our data suggest that CM extract stimulated 
transepithelial Cl- secretion in 16HBE14o- cells through apical CFTR Cl- channels and/or 
CaCCs. Basolateral cAMP- or Ca2+-activated K+ channels were activated by CM extract to 
provide a driving force for apical Cl- secretion. The underlying signal transduction 
mechanisms involve both cAMP- and Ca2+-dependent pathways (Fung et al., 2011).  
The pharmacological properties of CM have been studied for more than 50 years since 
cordycepin (3′-deoxyadenosine) was isolated from CM (Cunningham et al., 1950). 
Cordycepin is a major bioactive component of CM and has been detected in different parts 
of the CM fruiting body, ranging from 0.16 to 0.25% (w/w) (Yue et al., 2008). In 16HBE14o- 
cells, apical or basolateral application of cordycepin resulted in a stimulation of ISC, which 
has been shown to be due to Cl- secretion (Fung et al., 2011). Both apical and basolateral 
addition of cordycepin stimulates a concentration-dependent increase in ISC (Fig. 2). 
 
Fig. 2. Stimulation of Cl- secretion by cordycepin in 16HBE14o- cells. (A) A representative ISC 
trace in response to cordycepin applied apically to 16HBE14o- epithelia (ap, 10 μM). The 
horizontal dotted line represents zero ISC. The transient current pulses are the result of 
intermittently clamping of the potential at 1 mV for the calculation of transepithelial 
resistance using Ohm’s law. The record is representative of six experiments.  
(B) Concentration-response curves for changes in ISC in response to cordycepin added either 
apically or basolaterally. Each point represents the mean ± S.E. for at least six experiments.  
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In order to ascertain which types of Cl- and/or K+ channels mediated the stimulation of Cl- 
secretion caused by cordycepin, the CFTR Cl- channel (CFTRinh172) and CaCC (DIDS) 
blockers as well as the intermediate conductance Ca2+-dependent (TRAM-34) and cAMP-
dependent K+ channel (293B) blockers were used. As shown in Figure 3, the current evoked 
by cordycepin could be significantly inhibited in the presence of Ca2+- and cAMP-dependent 






Fig. 3. Effects of Cl- (A) and K+ (B) channel blockers on ISC responses to cordycepin. The 
control was the apical or basolateral application of cordycepin (10 μM) alone. Each column 
represents the mean ± S.E. (**p < 0.01, ***p < 0.001, Student’s t test compared with control,  
n = 4–5).  
The cordycepin-evoked ISC was sensitive to both cAMP- and Ca2+-dependent channel 
blockers, suggesting that Cl- secretion was mediated by these two signaling molecules. 
Indeed, the cordycepin-evoked ISC could be inhibited by the adenylate cyclase inhibitor, 
MDL-12330A, and the protein kinase A inhibitor, H-89. Adenylate cyclase is responsible for 
the generation of intracellular cAMP, while protein kinase A is the downstream signaling 
target of cAMP. Therefore, both CFTR Cl- channels and cAMP-dependent K+ channels 
expressed in 16HBE14o- cells could by stimulated by cordycepin through the activation of 
the cAMP/protein kinase A signaling pathway (Bleich and Warth, 2000; Li and Naren, 
2010). In addition to the activation of the cAMP-dependent pathway, cordycepin evoked a 
concentration-dependent increase in intracellular [Ca2+] as measured by Fura-2 imaging 
(Lau et al., 2011) (Fig. 4). Our experimental data, therefore, indicate that cordycepin exerts a 
similar prosecretory action and activates the same signal transduction pathways, namely 
Ca2+ and cAMP, in human airway epithelia compared with CM extract, suggesting that 







Fig. 4. Concentration-response curve for changes in [Ca2+]i (represented by 340/380 nm 
Fura-2 ratio) elicited by cordycepin (in μM). Changes in [Ca2+]i were plotted against the 
logarithm of cordycepin concentration (n = 4–9). Each data point represents the mean ± S.E. 
4. Anti-inflammatory effects of CM extract 
4.1 Role of airway epithelium in inflammation 
In addition to the regulation of electrolyte and fluid transport, airway epithelia also play a 
key role as regulators of inflammation and immunity (Bals and Hiemstra, 2004). The airway 
epithelium participates in inflammation in many ways. The cells can act as targets that 
respond to exposure to a variety of inflammatory mediators and cytokines by altering one or 
several of their functions, such as mucin secretion or ion transport (Adler et al., 1994). 
Moreover, the surface epithelium itself is responsible for the synthesis and release of 
cytokines that cause the selective recruitment, retention, and accumulation of various 
inflammatory cells (Jeffery, 2000). Certain inflammatory cytokines alter the fluid and 
electrolyte transport of the airway epithelium. Therefore, airway diseases, such as asthma, 
can be considered diseases of the bronchial epithelium, which could contribute to the 
pathophysiology of airway inflammation (Holgate et al., 1999).  
4.2 Cytokines as bronchial epithelial ion transport regulators 
Recent studies suggest that certain inflammatory cytokines affect transepithelial ion 
transport. The T-helper 1 cytokine, interferon-Ǆ (IFN-Ǆ), inhibits both Na+ reabsorption and 
cAMP-mediated Cl- secretion in human bronchial epithelial cells (Galietta et al., 2000). This 
is due to the downregulation of epithelial Na+ channel and CFTR activities. In contrast, IFN-
Ǆ upregulates the Ca2+-dependent Cl- secretion that is stimulated by UTP (Galietta et al., 
2000), which binds to P2Y2 receptors (Mason et al., 1991). The net effect is a reduction in 
fluid absorption, which favors the hydration of mucus secretion. In 16HBE14o- cells, both 
IL-9 and IL-13 augment UTP-induced Cl- secretion via the increased expression of hCLCA1, 
a Ca2+-activated Cl- channel (Endo et al., 2007). Inhibition of CaCCs by niflumic acid has 
been shown to control IL-13-induced asthma phenotypes by suppressing JAK/STAT6 
activation (Nakano et al., 2006). Therefore, certain cytokines change the balance between 
fluid absorption and secretion to favor hydration of the airway surface and, consequently, 
mucus clearance (Galietta et al., 2004).  
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4.3 Anti-inflammatory effects of CM extract 
Both CM and cordycepin have been shown to possess anti-inflammatory activities against in 
vitro and in vivo models of inflammation (Cheng et al., 2011; Han et al., 2011; Jeong et al., 
2010). CPS-1, a polysaccharide purified from CM extract, was shown to have anti-
inflammatory effects in mice, possibly via the suppression of humoral immunity (Yu et al., 
2004). Similar anti-inflammatory effects of CM extract and cordycepin were also observed in 
a study by Won and Park (Won and Park, 2005). CM extract also suppressed intestinal 
inflammation in an acute colitic mouse model by inhibiting the level of pro-inflammatory 
cytokine mediators, such as TNFǂ (Han et al., 2011). In microglia, cordycepin is capable of 
inhibiting the expression of pro-inflammatory cytokines, such as TNFǂ and IL-1ǃ (Jeong et 
al., 2010). However, there have been very few studies addressing the anti-inflammatory 
effects of Cordyceps extracts or cordycepin in the respiratory system. Hsu et al. reported that 
CM extract can modulate airway inflammation in a mouse model of asthma, but the 
therapeutic effects are less than those of two commonly used western medicines, namely 
prednisolone and montelukast (Hsu et al., 2008). On the contrary, a recent randomized, 
double-blind, placebo-controlled trial in asthmatic children (Wong et al., 2009b) challenged 
the use of CS extract as an asthma therapy. In this study, children with asthma were treated 
with a herbal formula of dried aqueous extracts of five herbs containing CS. However, no 
significant differences were found between the treated group and the placebo group (Wong 
et al., 2009b). Therefore, there is still controversy over the treatment of asthma using 
Cordyceps extracts.  
5. Conclusion 
In summary, CM extract stimulates anion secretion from both surface epithelia of the 
airways (16HBE14o- cells) and submucosal glands (Calu-3 cells). Figure 5 shows the cellular 
signaling mechanisms underlying the effects of CM extract and cordycepin. Enhancing fluid 
and electrolyte transport may improve both airway surface hydration and mucus clearance, 
which becomes hypersecreted in various respiratory diseases, such as asthma and COPD. 
Therefore, this stimulatory effect of CM extract and cordycepin on major secretory cell types 
of the upper airways may account for its traditional use in treating different respiratory 
diseases. Our previous study suggests that 16HBE14o- cells can secrete interleukin- (IL-) 6 
and IL-8, two important pro-inflammatory cytokines, towards the mucosal side in a 
polarized fashion (Chow et al., 2010). This phenomenon may contribute to the 
pathophysiology of asthmatic inflammation and the development of other inflammatory 
lung diseases (Chow et al., 2010). Therefore, the therapeutic effects of CM and cordycepin on 
airway diseases may be attributed to their influences on immune response regulation (Das 
et al., 2010), although the detailed molecular mechanisms await to be elucidated. 
Further study is required to delineate the immunomodulatory effects of CM extract and 
cordycepin in both normal and diseased airway epithelia. In particular, it would be 
interesting to determine whether the stimulatory effects on ion transport could be attributed 
to cytokine secretion. Further experiments are needed to purify and characterize the other 
active component(s) present in the CM extract and determine the mechanisms of action for 
their therapeutic effects since the prosecretory action of CM extract is not solely explained 
by the presence of cordycepin. Calu-3 and 16HBE14o- cells are models for submucosal 






types, such as goblet (mucous) cells, which secrete mucins. Goblet cell hyperplasia or 
metaplasia is commonly seen in airway diseases, such as asthma, COPD, and chronic 
bronchitis (Rogers, 2007). It is important to examine whether CM extract or cordycepin has 
any effect on mucus secretion by goblet cells. Finally, more carefully conducted clinical trials 
should be performed to evaluate the therapeutic potential of CM extract and its major 































Fig. 5. Cellular mechanisms underlying the prosecretory effects of CM extract and 
cordycepin. 
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